Abstract
The association between the polycystic ovary syndrome (PCOS) and insulin resistance has led to the use of insulin-sensitizing drugs to induce ovulations. Metformin was shown to lower insulin levels effectively, and metformin alone, as well as in combination with clomiphene citrate (CC), has been shown to enhance ovulation in PCOS patients. However, insulin-sensitizing medications have considerable side-effects, and lifestyle improvements (weight reduction and increased exercise) should be considered as first-line treatments in overweight women with PCOS. At present, metformin may best be used as an adjuvant therapy in CC-refractory PCOS patients.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
